Target Name: SLC12A9
NCBI ID: G56996
Review Report on SLC12A9 Target / Biomarker Content of Review Report on SLC12A9 Target / Biomarker
SLC12A9
Other Name(s): SLC12A9 variant 3 | CCC6 | Potassium-chloride transporter 9 | Solute carrier family 12 member 9, transcript variant 1 | solute carrier family 12 member 9 | hCCC6 | cation-chloride cotransporter-interacting protein 1 | CCC-interacting protein 1 | Solute carrier family 12 member 9, transcript variant 3 | Solute carrier family 12 member 9 (isoform 3) | Cation-chloride cotransporter-interacting protein 1 | Cation-chloride cotransporter 6 | potassium-chloride transporter 9 | Solute carrier family 12 member 9 | WO3.3 | Solute carrier family 12 member 9 (SLC12A9) | hCIP1 | cation-chloride cotransporter 6 | SLC12A9 variant 1 | solute carrier family 12 (potassium/chloride transporters), member 9 | Solute carrier family 12 (potassium/chloride transporters), member 9 | S12A9_HUMAN | Solute carrier family 12 member 9 (isoform 1) | CIP1

SLC12A9: A Potential Drug Target for Ion and Water Transport

SLC12A9 is a gene that encodes a protein known as solute carrier family 12 member 9. This protein is a type of transmembrane protein that is involved in the transport of various molecules across the membrane of cells. SLC12A9 is expressed in many different tissues and cells in the body, including the brain, heart, and kidneys.

One of the unique features of SLC12A9 is its variable region. The variable region is a region of the protein that is responsible for its unique structure and function. In the case of SLC12A9, the variable region contains several unique domains that give the protein its unique structure and help it to interact with other molecules.

One of the most interesting aspects of SLC12A9 is its potential as a drug target. The SLC12A9 protein has been shown to play a role in a variety of physiological processes in the body, including the regulation of ion and water transport. This makes it an attractive target for researchers who are interested in developing new treatments for a variety of diseases.

One of the ways that SLC12A9 has been studied is through its expression levels. Researchers have found that SLC12A9 is highly expressed in many different tissues and cells in the body, including the brain, heart, and kidneys. This suggests that it may be an important protein for a variety of physiological processes in the body.

Another way that researchers have studied SLC12A9 is through its function. Studies have shown that SLC12A9 plays a role in the regulation of ion and water transport in various tissues and cells in the body. This helps to ensure that cells have access to the necessary nutrients and oxygen, and that waste products are properly removed from the body.

In addition to its role in ion and water transport, SLC12A9 has also been shown to play a role in the regulation of cell signaling pathways. This suggests that it may be involved in a variety of signaling processes that are important for maintaining the health and integrity of cells.

Overall, SLC12A9 is a protein that has a great deal of potential as a drug target. Its unique structure and function, as well as its high expression levels in many different tissues and cells in the body, make it an attractive target for researchers who are interested in developing new treatments for a variety of diseases.

Protein Name: Solute Carrier Family 12 Member 9

Functions: May be an inhibitor of SLC12A1. Seems to correspond to a subunit of a multimeric transport system and thus, additional subunits may be required for its function

The "SLC12A9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC12A9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

SLC13A1 | SLC13A2 | SLC13A3 | SLC13A4 | SLC13A5 | SLC14A1 | SLC14A2 | SLC15A1 | SLC15A2 | SLC15A3 | SLC15A4 | SLC15A5 | SLC16A1 | SLC16A10 | SLC16A11 | SLC16A12 | SLC16A13 | SLC16A14 | SLC16A2 | SLC16A3 | SLC16A4 | SLC16A5 | SLC16A6 | SLC16A6P1 | SLC16A7 | SLC16A8 | SLC16A9 | SLC17A1 | SLC17A2 | SLC17A3 | SLC17A4 | SLC17A5 | SLC17A6 | SLC17A7 | SLC17A8 | SLC17A9 | SLC18A1 | SLC18A2 | SLC18A3 | SLC18B1 | SLC19A1 | SLC19A2 | SLC19A3 | SLC1A1 | SLC1A2 | SLC1A3 | SLC1A4 | SLC1A5 | SLC1A6 | SLC1A7 | SLC20A1 | SLC20A1-DT | SLC20A2 | SLC22A1 | SLC22A10 | SLC22A11 | SLC22A12 | SLC22A13 | SLC22A14 | SLC22A15 | SLC22A16 | SLC22A17 | SLC22A18 | SLC22A18AS | SLC22A2 | SLC22A20P | SLC22A23 | SLC22A24 | SLC22A25 | SLC22A3 | SLC22A31 | SLC22A4 | SLC22A5 | SLC22A6 | SLC22A7 | SLC22A8 | SLC22A9 | SLC23A1 | SLC23A2 | SLC23A3 | SLC24A1 | SLC24A2 | SLC24A3 | SLC24A3-AS1 | SLC24A4 | SLC24A5 | SLC25A1 | SLC25A10 | SLC25A11 | SLC25A12 | SLC25A13 | SLC25A14 | SLC25A15 | SLC25A16 | SLC25A17 | SLC25A18 | SLC25A19 | SLC25A2 | SLC25A20 | SLC25A21